Evidence map›Paper›PMID 34467853›Full record

ArticleeLife2021

Katarina Akhmetova, Maxim Balasov, Igor Chesnokov

Open access · goldAbstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. The "yeast-drop" treatment protocol in theFrontiers in tuberculosis · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Katarina AkhmetovaDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, School of Medicine, Birmingham, United States.ORCID 0000-0003-2475-3288
Maxim BalasovDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, School of Medicine, Birmingham, United States.
Igor ChesnokovDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, School of Medicine, Birmingham, United States.ORCID 0000-0002-6659-2913
University of Alabama at Birmingham · US

Funding

The role of Orc6 in DNA replication and cytokinesis.R01GM121449 · NIGMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CHESNOKOV, IGOR N · 2017 to 2023
$2.6M
NIGMS NIH HHS R01 GM121449
6 · The paper itself

Abstract

Stimulator of interferon genes (STING) plays an important role in innate immunity by controlling type I interferon response against invaded pathogens. In this work, we describe a previously unknown role of STING in lipid metabolism in

Indexed as

Drosophila ProteinsMembrane ProteinsAcetyl-CoA CarboxylaseAnimalsDrosophila melanogasterFatty Acid SynthasesFemaleGene DeletionGene Knockout TechniquesLipid MetabolismMaleSTING ProteinAcetyl-CoA CarboxylaseDrosophila ProteinsFatty Acid SynthasesMembrane ProteinsSTING ProteinSting protein, Drosophilabiochemistrychemical biologyD. melanogasterDrosophilageneticsgenomicslipid metabolismSTING

Identifiers

PMID34467853
PMCPMC8443252
OpenAlexW3197148946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.